Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $885K 4,627 sh |
| Jan 8, 2026 traded Jan 8, 2026 |
| 22 | Smith Michael AlexanderChief Legal Officer | Open-market sale | SELL | $183K 1,053 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 22 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $306K 1,582 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 22 | Smith Michael AlexanderChief Legal Officer | Open-market sale | SELL | $242K 1,396 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 22 | Foote TimChief Financial Officer | Open-market sale | SELL | $3,147 811 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 22 | Smith Michael AlexanderChief Legal Officer | Open-market sale | SELL | $124K 709 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 22 | Mills MattPresident | Open-market sale · 10b5-1 plan | SELL | $361K 18.2K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 21 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.14M 5,647 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 20 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $40K 202 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $185K 946 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Gnanasambandam ChandrasekarEVP Product & CTO | Open-market sale · 10b5-1 plan | SELL | $83K 4,245 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Payne AbbyChief People Officer | Open-market sale · 10b5-1 plan | SELL | $70K 3,582 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Rezvan MitraChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $74K 3,782 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Payne AbbyChief People Officer | Open-market sale · 10b5-1 plan | SELL | $186K 9,329 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Robins Harlan SChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $164K 10.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 19 | Rezvan MitraChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $76K 3,821 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $244K 1,255 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Gnanasambandam ChandrasekarEVP Product & CTO | Open-market sale · 10b5-1 plan | SELL | $87K 4,360 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Schmitt ChristopherGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $202K 10.1K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Schmitt ChristopherGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $88K 4,507 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $512K 2,543 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $841K 4,447 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $919K 4,610 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Issa Mohamed KhairieEVP, Head of US Oncology | Open-market sale · 10b5-1 plan | SELL | $1.18M 10.9K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $814K 4,099 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Shipchandler KhozemaDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.50M 11.1K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $712K 3,815 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 18 | Gravier PierreCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $165K 2,139 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $33K 9,722 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $35K 9,722 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 17 | Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $396K 5,149 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $36K 9,730 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Borgeson BlakeDirector | Open-market sale · 10b5-1 plan | SELL | $959K 220.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 15 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $216K 1,121 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 15 | Peterson Neil W.CHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $450K 5,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 14 | Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $234K 3,016 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 14 | Schlosser MarioDirector, President of Technology & CTO | Open-market sale · 10b5-1 plan | SELL | $1.31M 77.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 13 | Smith Chad M.Pres & COO, Better Mortgage | Open-market sale · 10b5-1 plan | SELL | $100K 2,843 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $830K 4,783 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 12 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $280K 1,615 sh | Jan 8, 2026 traded Jan 6, 2026 |